Literature DB >> 32533515

Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator.

Hisashi Takei1,2, Hirofumi Fukuda3, Gilbert Pan1, Hiroyuki Yamazaki3, Tadahiko Matsumoto3, Yasuhiro Kazuma3, Masanori Fujii1, Sohei Nakayama1, Ikei S Kobayashi1, Keisuke Shindo3, Riu Yamashita4, Kotaro Shirakawa3, Akifumi Takaori-Kondo3, Susumu S Kobayashi5,6,7.   

Abstract

The apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) protein family members have cytidine deaminase activity and can induce cytosine to uracil transition in nucleic acid. The main function of APOBEC3 (A3) proteins is to trigger an innate immune response to viral infections. Recent reports have shown that several APOBEC family proteins such as A3B can induce somatic mutations into genomic DNA and thus promote cancer development. However, the role of A3D on somatic mutations is unclear. Here, we identified the alternative splicing of A3D, and investigated each splice variant's subcellular localization and role in DNA mutagenesis. We identified four A3D variants, which all have one or two cytidine deaminase domains. The full-length form of A3D (variant 1) and truncated forms of A3D (variant 2, 6, 7) showed the ability to induce C/G to T/A transitions in foreign DNA and genomic DNA and retained antiretroviral activity. Furthermore, we demonstrated that A3D and A3B could induce deletions that are possibly repaired by microhomology-mediated end joining (MMEJ). Taken together, our experiments illustrated that alternative splicing generates functional diversity of A3D, and some variants can act as DNA mutators in genomic DNA.

Entities:  

Keywords:  Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3D (APOBEC3D); Cytidine deaminase; Leukemia; Mutations; Resistance

Mesh:

Substances:

Year:  2020        PMID: 32533515      PMCID: PMC8713138          DOI: 10.1007/s12185-020-02904-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  37 in total

1.  Structural Insights into HIV-1 Vif-APOBEC3F Interaction.

Authors:  Masaaki Nakashima; Hirotaka Ode; Takashi Kawamura; Shingo Kitamura; Yuriko Naganawa; Hiroaki Awazu; Shinya Tsuzuki; Kazuhiro Matsuoka; Michiko Nemoto; Atsuko Hachiya; Wataru Sugiura; Yoshiyuki Yokomaku; Nobuhisa Watanabe; Yasumasa Iwatani
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

Review 2.  Retroviral restriction by APOBEC proteins.

Authors:  Reuben S Harris; Mark T Liddament
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

3.  The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.

Authors:  Qihan Chen; Xiao Xiao; Aaron Wolfe; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2016-04-08       Impact factor: 5.469

4.  Evidence for APOBEC3B mutagenesis in multiple human cancers.

Authors:  Michael B Burns; Nuri A Temiz; Reuben S Harris
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

7.  APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.

Authors:  Masanobu Shinohara; Katsuhiro Io; Keisuke Shindo; Masashi Matsui; Takashi Sakamoto; Kohei Tada; Masayuki Kobayashi; Norimitsu Kadowaki; Akifumi Takaori-Kondo
Journal:  Sci Rep       Date:  2012-11-13       Impact factor: 4.379

8.  Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.

Authors:  Niklas Feldhahn; Nadine Henke; Kai Melchior; Cihangir Duy; Bonaventure Ndikung Soh; Florian Klein; Gregor von Levetzow; Bernd Giebel; Aihong Li; Wolf-Karsten Hofmann; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

Review 9.  AID/APOBEC deaminases and cancer.

Authors:  Stefan Rebhandl; Michael Huemer; Richard Greil; Roland Geisberger
Journal:  Oncoscience       Date:  2015-04-28

Review 10.  The role of cytidine deaminases on innate immune responses against human viral infections.

Authors:  Valdimara C Vieira; Marcelo A Soares
Journal:  Biomed Res Int       Date:  2013-06-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.